Fibroblast growth factor 9 stimulates steroidogenesis in postnatal Leydig cells

Yung Ming Lin, Chih Chien Tsai, Chia Ling Chung, Pei Rong Chen, H. Sunny Sun, Shaw Jenq Tsai, Bu Miin Huang

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)


Fibroblast growth factor 9 (FGF9) is a potent mitogen and survival factor required for morphogenesis during embryonic development and numerous biological functions at adulthood. The reproductive phenotype of mice lacking Fgf9 gene exhibits male to female sexual reversal, suggesting a crucial role of Fgf9 in male sex determination. Our previous study showed that polymorphic microsatellite of FGF9 genes is associated with 46XY female with ambiguous genitalia, implying that the aberrant expression of FGF9 might affect androgen secretion. In this study, we aimed to investigate the effect of FGF9 on testosterone production in mouse Leydig cell and to study the signalling pathways by which FGF9 modulate steroidogenesis. Our results show that mRNAs of Fgf9 and Fgfr isoforms (Fgfr2IIIc, Fgfr3 and Fgfr4) were all expressed in mouse Leydig cells. FGF9 significantly stimulates mouse Leydig cell testosterone production in a dose- and time-dependent manner. Ras-MAPK, PI3K and PKA signalling pathways are involved in the FGF9-induced steroidogenesis. These results provide supportive evidence linking the aberrant expression of FGF9 to human gonadal dysgenesis and suggest a role of FGF9 in postnatal testicular development.

Original languageEnglish
Pages (from-to)545-553
Number of pages9
JournalInternational Journal of Andrology
Issue number3
Publication statusPublished - 2010 Jun

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Urology


Dive into the research topics of 'Fibroblast growth factor 9 stimulates steroidogenesis in postnatal Leydig cells'. Together they form a unique fingerprint.

Cite this